Back
Speaker illustration

Associate Professor Iryna Vyshnevska

L.T. Malaya Therapy National institute of NAMSU, Kharkiv (Ukraine)

PRESENT POSITION/ TITLE Position: Senior Researcher Therapy National Institute, CRA, Medical Study Monitor, PRESC1SE-MI, Cardiovascular Research Institute Basel, University of Basel Title: MD, PhD, Associate Professor (academic rank) Education: Cardiologist high qualification category from 2023 Internal Medicine high qualification category from 2019 2013-2013 - Kharkiv medical academy of postgraduate education Cardiology № 528 2009-2011 - Kharkov National Medical University, Internal Medicine (residency) 2007-2009 -Kharkiv National Medical University,Internal Medicine (internship) № 3755 2001-2007 - Kharkiv National Medical University, General Medicine ХА № 32470069 Professional background (additional): 2010 -2022 V. N. Karazin Kharkiv National University, medical faculty, department of General and Clinical Pathology, Associate professor

Presentations Articles

Prognostic value of echocardiographic parameters in predicting major adverse cardiac events one year following st-segment elevation myocardial infarction

Event: ESC Congress 2024

Topic: Left Ventricular Remodelling

Session: Multimodality imaging in acute coronary syndromes

Access
Like
Thumbnail

Predicting adverse cardiac remodeling after ST-elevation myocardial infarction with novel biomarkers soluble isoform of suppression tumorigenicity-2 and macrophage migration inhibitory factor

Event: Heart Failure 2024

Topic: Biomarkers

Session: Basic science - cardiac disease 1

Access
Like
Thumbnail

HFWM: evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction

Event: Heart Failure 2024

Topic: Biomarkers

Session: ePosters in basic science 2

Access
Like
Thumbnail

The predictive value of matrix metalloproteinase-9 as an inflammation marker in anticipating adverse events one year after experiencing a st-elevation myocardial infarction

Event: Heart Failure 2024

Topic: Biomarkers

Session: ePosters in basic science 2

Access
Like
Thumbnail

Predicting adverse cardiac remodeling following ST-elevation myocardial infarction through the assessment of endothelin-1 levels

Event: EHRA 2024

Topic: Cardiac Diseases

Session: Poster session on devices, others

Access
Like
Thumbnail

Evaluating the importance of myeloperoxidase in the early anticipation of subsequent chronic heart failure occurrences in individuals after st-segment elevation acute myocardial infarction

Event: HFA Winter Research Meeting on Translational Heart Failure 2024

Topic: Biomarkers

Session: Poster Session

Access
Like
Thumbnail

Role of matrix metalloproteinase 9 in prediction composite one-year endpoint in st-segment elevation myocardial infarction

Event: Heart Failure 2023

Topic: Biomarkers

Session: Basic science - cardiac disease 3

Access
Like
Thumbnail

Macrophage migration inhibitory factor as a predictor of left ventricle remodeling in stemi patients

Event: Heart Failure 2022

Topic: Left Ventricular Remodelling

Session: Heart Failure ePosters - focus on CAD / CSS / ACS / ACC

Access
Like
Thumbnail

Macrophage migration inhibitory factor as a risk marker for post-infarction heart failure 6-month after st-segment elevation myocardial infarction

Event: Heart Failure 2022

Topic: Left Ventricular Remodelling

Session: Heart Failure ePosters - focus on CAD / CSS / ACS / ACC

Access
Like
Thumbnail

Biomarkers as a prognostic factor for post-infarction adverse left ventricle remodeling 6-month after stemi

Event: Heart Failure 2022

Topic: Left Ventricular Remodelling

Session: Heart Failure ePosters - focus on CAD / CSS / ACS / ACC

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources